A-262: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:A-262 (Novichok agent)}} | ||
== A-262 (Novichok agent) == | |||
[[File:Novichok_A262_(Mirzayanov_2009).svg|thumb|right|Chemical structure of A-262]] | |||
A-262 is a chemical compound classified as a [[nerve agent]] and is part of the [[Novichok]] family of agents. These agents were developed in the [[Soviet Union]] during the late stages of the [[Cold War]] as part of a program to create more potent chemical weapons that could evade international detection and bans. | |||
== | == Chemical Properties == | ||
A-262, like other Novichok agents, is an [[organophosphate]] compound. It is designed to inhibit the enzyme [[acetylcholinesterase]], leading to an accumulation of [[acetylcholine]] in the [[synaptic cleft]] and causing continuous stimulation of [[muscle]]s, [[gland]]s, and [[central nervous system]] functions. | |||
== | == Mechanism of Action == | ||
The primary mechanism of action for A-262 involves the irreversible binding to the active site of acetylcholinesterase. This binding prevents the breakdown of acetylcholine, resulting in prolonged [[neuromuscular]] transmission and [[cholinergic crisis]]. Symptoms of exposure can include [[muscle twitching]], [[respiratory failure]], [[convulsions]], and potentially [[death]]. | |||
== Toxicity and Effects == | |||
A-262 is highly toxic, with effects similar to other nerve agents such as [[sarin]] and [[VX]]. Exposure can occur through [[inhalation]], [[skin contact]], or [[ingestion]]. The rapid onset of symptoms necessitates immediate medical intervention, typically involving the administration of [[atropine]] and [[pralidoxime]] to counteract the effects. | |||
== History and Development == | |||
The development of A-262 and other Novichok agents was part of a clandestine effort by the Soviet Union to create chemical weapons that could bypass existing [[arms control]] measures. The existence of these agents was not widely known until the 1990s, when former Soviet scientist [[Vil Mirzayanov]] revealed details about the program. | |||
== Detection and Decontamination == | |||
Detection of A-262 requires specialized equipment capable of identifying trace amounts of the compound. Decontamination procedures involve the use of [[reactive skin decontamination lotion]] (RSDL) and other chemical neutralizers to remove the agent from surfaces and skin. | |||
== Related Pages == | |||
* [[Novichok agent]] | * [[Novichok agent]] | ||
* [[Nerve agent]] | |||
* [[Chemical warfare]] | * [[Chemical warfare]] | ||
* [[Acetylcholinesterase inhibitor]] | * [[Acetylcholinesterase inhibitor]] | ||
[[Category:Chemical warfare agents]] | [[Category:Chemical warfare agents]] | ||
[[Category:Nerve agents]] | [[Category:Nerve agents]] | ||
Latest revision as of 11:34, 15 February 2025
A-262 (Novichok agent)[edit]
.svg)
A-262 is a chemical compound classified as a nerve agent and is part of the Novichok family of agents. These agents were developed in the Soviet Union during the late stages of the Cold War as part of a program to create more potent chemical weapons that could evade international detection and bans.
Chemical Properties[edit]
A-262, like other Novichok agents, is an organophosphate compound. It is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system functions.
Mechanism of Action[edit]
The primary mechanism of action for A-262 involves the irreversible binding to the active site of acetylcholinesterase. This binding prevents the breakdown of acetylcholine, resulting in prolonged neuromuscular transmission and cholinergic crisis. Symptoms of exposure can include muscle twitching, respiratory failure, convulsions, and potentially death.
Toxicity and Effects[edit]
A-262 is highly toxic, with effects similar to other nerve agents such as sarin and VX. Exposure can occur through inhalation, skin contact, or ingestion. The rapid onset of symptoms necessitates immediate medical intervention, typically involving the administration of atropine and pralidoxime to counteract the effects.
History and Development[edit]
The development of A-262 and other Novichok agents was part of a clandestine effort by the Soviet Union to create chemical weapons that could bypass existing arms control measures. The existence of these agents was not widely known until the 1990s, when former Soviet scientist Vil Mirzayanov revealed details about the program.
Detection and Decontamination[edit]
Detection of A-262 requires specialized equipment capable of identifying trace amounts of the compound. Decontamination procedures involve the use of reactive skin decontamination lotion (RSDL) and other chemical neutralizers to remove the agent from surfaces and skin.
